Literature DB >> 15763602

The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management.

Dieter Felsenberg1, Steven Boonen.   

Abstract

BACKGROUND: Bone mineral density (BMD) measurements are the standard tool in the diagnosis of osteoporosis. However, recent developments in bone research show that a BMD measurement, while still important in a clinical setting, is in itself insufficient to accurately predict fracture risk or measure treatment effects of an antiosteoporosis drug. Clinical experience with patient follow-up strongly suggests that bone quality must also be taken into account.
OBJECTIVES: The objectives of this paper are. (1) to describe the determinants of bone strength (structural and material properties of bone, both of which are affected by bone turnover) and their interrelationships, and (2) to provide a schematic explanation of these determinants of bone strength, which in this paper is referred to as the Bone Quality Framework.
METHODS: Relevant information from the primary literature and review articles published in the English language were identified through a MEDLINE search of the medical literature, from 1990 to October 2004, in the fields of bone density, bone strength, bone quality, fracture risk, and fracture risk reduction. Additional publications were identified from the reference lists of the resulting articles. Identified publications relevant to the objectives of this review paper were selected.
CONCLUSIONS: The Bone Quality Framework is presented in this paper as a means of summarizing and explaining the determinants of bone strength. In this framework, bone quality can be understood as an umbrella term that describes the set of characteristics that influence bone strength and explains the interrelationships of these characteristics. Bone strength depends on the structural and material properties of bone, both of which are influenced by the rate of bone turnover. Not all determinants of bone strength are well represented by a BMD measurement. The Bone Quality Framework presents an opportunity to examine all the determinants of bone strength. Greater understanding of the concept of bone quality will ultimately help improve the assessment of fracture risk and monitoring of patients receiving treatment for osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15763602     DOI: 10.1016/j.clinthera.2004.12.020

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  94 in total

1.  Obesity alters cortical and trabecular bone density and geometry in women.

Authors:  D Sukumar; Y Schlussel; C S Riedt; C Gordon; T Stahl; S A Shapses
Journal:  Osteoporos Int       Date:  2010-06-09       Impact factor: 4.507

Review 2.  New targets for intervention in the treatment of postmenopausal osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Nat Rev Rheumatol       Date:  2011-09-20       Impact factor: 20.543

3.  Reproducibility of peripheral quantitative computed tomography measurements at the radius and tibia in healthy pre- and postmenopausal women.

Authors:  Kristina A Szabo; Colin E Webber; Christopher Gordon; Jonathan D Adachi; Richard Tozer; Alexandra Papaioannou
Journal:  Can Assoc Radiol J       Date:  2010-06-23       Impact factor: 2.248

Review 4.  Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.

Authors:  Teresita Bellido; Lilian I Plotkin
Journal:  Bone       Date:  2010-08-18       Impact factor: 4.398

Review 5.  Assessment of bone mineral and matrix using backscatter electron imaging and FTIR imaging.

Authors:  Adele L Boskey
Journal:  Curr Osteoporos Rep       Date:  2006-06       Impact factor: 5.096

Review 6.  A biomechanical perspective on bone quality.

Authors:  C J Hernandez; T M Keaveny
Journal:  Bone       Date:  2006-07-28       Impact factor: 4.398

Review 7.  [New techniques for the diagnosis of osteoporosis].

Authors:  A S Issever; T M Link
Journal:  Radiologe       Date:  2006-10       Impact factor: 0.635

8.  Strong association between polymorphisms in ANKH locus and skeletal size traits.

Authors:  Ida Malkin; Sergey Ermakov; Eugene Kobyliansky; Gregory Livshits
Journal:  Hum Genet       Date:  2006-04-26       Impact factor: 4.132

Review 9.  Bone mineral density deficits and fractures in survivors of childhood cancer.

Authors:  Carmen L Wilson; Kirsten K Ness
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

10.  Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material properties.

Authors:  Maxime A Gallant; Drew M Brown; Max Hammond; Joseph M Wallace; Jiang Du; Alix C Deymier-Black; Jonathan D Almer; Stuart R Stock; Matthew R Allen; David B Burr
Journal:  Bone       Date:  2014-01-24       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.